You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 2, July 11, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •JAMA News Video
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Pediatrics
 •Pediatrics, Other
 •Urinary Tract Disorders
 •Drug Therapy, Other
 •Alert me on articles by topic

Recurrent Urinary Tract Infections in Children

Risk Factors and Association With Prophylactic Antimicrobials

Patrick H. Conway, MD, MSc; Avital Cnaan, PhD; Theoklis Zaoutis, MD, MSCE; Brandon V. Henry, BS; Robert W. Grundmeier, MD; Ron Keren, MD, MPH

JAMA. 2007;298:179-186.

Context  The evidence regarding risk factors for recurrent urinary tract infection (UTI) and the risks and benefits of antimicrobial prophylaxis in children is scant.

Objectives  To identify risk factors for recurrent UTI in a pediatric primary care cohort, to determine the association between antimicrobial prophylaxis and recurrent UTI, and to identify the risk factors for resistance among recurrent UTIs.

Design, Patients, and Setting  From a network of 27 primary care pediatric practices in urban, suburban, and semirural areas spanning 3 states, a cohort of children aged 6 years or younger who were diagnosed with first UTI between July 1, 2001, and May 31, 2006, was assembled. Time-to-event analysis was used to determine risk factors for recurrent UTI and the association between antimicrobial prophylaxis and recurrent UTI, and a nested case-control study was performed among children with recurrent UTI to identify risk factors for resistant infections.

Main Outcome Measures  Time to recurrent UTI and antimicrobial resistance of recurrent UTI pathogens.

Results  Among 74 974 children in the network, 611 (0.007 per person-year) had a first UTI and 83 (0.12 per person-year after first UTI) had a recurrent UTI. In multivariable Cox time-to-event models, factors associated with increased risk of recurrent UTI included white race (0.17 per person-year; hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.22-3.16), age 3 to 4 years (0.22 per person-year; HR, 2.75; 95% CI, 1.37-5.51), age 4 to 5 years (0.19 per person-year; HR, 2.47; 95% CI, 1.19-5.12), and grade 4 to 5 vesicoureteral reflux (0.60 per person-year; HR, 4.38; 95% CI, 1.26-15.29). Sex and grade 1 to 3 vesicoureteral reflux were not associated with risk of recurrence. Antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI (HR, 1.01; 95% CI, 0.50-2.02), even after adjusting for propensity to receive prophylaxis, but was a risk factor for antibimicrobial resistance among children with recurrent UTI (HR, 7.50; 95% CI, 1.60-35.17).

Conclusion  Among the children in this study, antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI, but was associated with increased risk of resistant infections.


Author Affiliations: Robert Wood Johnson Foundation Clinical Scholars Program (Dr Conway), Leonard Davis Institute of Health Economics (Drs Conway, Zaoutis, and Keren), Center for Clinical Epidemiology and Biostatistics (Drs Conway, Cnaan, Zaoutis, and Keren), and School of Medicine (Mr Henry), University of Pennsylvania, Philadelphia; Division of General Pediatrics (Drs Conway, Zaoutis, and Keren), Division of Biostatistics and Epidemiology (Dr Cnaan), and Center for Biomedical Informatics (Dr Grundmeier), Children's Hospital of Philadelphia; and Center for Health Care Quality and Division of General Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (Dr Conway).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Persistence of Escherichia coli Clones and Phenotypic and Genotypic Antibiotic Resistance in Recurrent Urinary Tract Infections in Childhood
Koljalg et al.
J. Clin. Microbiol. 2009;47:99-105.
ABSTRACT | FULL TEXT  

Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Children With Vesicoureteral Reflux Receiving Prophylactic Antibiotic Therapy
Cheng et al.
Pediatrics 2008;122:1212-1217.
ABSTRACT | FULL TEXT  

Introduction
Keren
Pediatrics 2008;122:S231-S232.
FULL TEXT  

Rationale and Design Issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) Study
Keren et al.
Pediatrics 2008;122:S240-S250.
ABSTRACT | FULL TEXT  

Prophylaxis After First Febrile Urinary Tract Infection in Children? A Multicenter, Randomized, Controlled, Noninferiority Trial
Montini et al.
Pediatrics 2008;122:1064-1071.
ABSTRACT | FULL TEXT  

Is Antibiotic Prophylaxis in Children With Vesicoureteral Reflux Effective in Preventing Pyelonephritis and Renal Scars? A Randomized, Controlled Trial
Pennesi et al.
Pediatrics 2008;121:e1489-e1494.
ABSTRACT | FULL TEXT  

Antibiotic prophylaxis does not prevent UTIs
Kemp
AAP News 2007;28:2-2.
FULL TEXT  

Does UTI Prophylaxis Cause More Harm Than Good?
Weidermann
AAP Grand Rounds 2007;18:25-26.
FULL TEXT  

Management of urinary tract infection in children
Watson
BMJ 2007;335:356-357.
FULL TEXT  

Prophylactic Antibiotic Therapy Does Not Prevent Recurrent UTI in Children
JWatch Pediatrics 2007;2007:1-1.
FULL TEXT  

Antibiotic Prophylaxis Does Not Lower Rate of Recurrent UTI in Children
JWatch Emergency Med. 2007;2007:1-1.
FULL TEXT  

Do Prophylactic Antibiotics Prevent Children's UTIs?
JWatch Infect. Diseases 2007;2007:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.